TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pharmaq Analytiq AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
7,477
|
7,717
|
7,480 |
| Financial expenses |
30
|
48
|
46 |
| Earnings before taxes |
-445
|
-62
|
-606 |
| Total assets |
3,866
|
3,594
|
4,777 |
| Current assets |
2,198
|
1,679
|
2,542 |
| Current liabilities |
2,066
|
1,766
|
2,755 |
| Equity capital |
1,767
|
1,808
|
1,982 |
| - share capital |
93
|
98
|
104 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
45.7%
|
50.3%
|
41.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-6.0%
|
-0.8%
|
-8.1% |
| Return on assets (ROA) |
-10.7%
|
-0.4%
|
-11.7% |
| Current ratio |
106.4%
|
95.1%
|
92.3% |
| Return on equity (ROE) |
-25.2%
|
-3.4%
|
-30.6% |
| Change turnover |
154
|
712
|
-367 |
| Change turnover % |
2%
|
10%
|
-5% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.